Skip to main content
Erschienen in: World Journal of Surgery 7/2014

01.07.2014

Pathological Confirmation of Para-Aortic Lymph Node Status as a Potential Criterion for the Selection of Intrahepatic Cholangiocarcinoma Patients for Radical Resection with Regional Lymph Node Dissection

verfasst von: Tomohide Nakayama, Takahiro Tsuchikawa, Toshiaki Shichinohe, Toru Nakamura, Yuma Ebihara, Satoshi Hirano

Erschienen in: World Journal of Surgery | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Para-aortic lymph node (PAN) metastasis traditionally has been defined as distant metastasis. Many studies suggest that lymph node metastasis in intrahepatic cholangiocarcinoma (ICC) is one of the strongest prognostic factors for patient survival; however, the status of the PAN was not examined separately from regional lymph node metastasis in these reports. Here, we investigated whether regional lymph node metastasis without PAN metastasis in ICC can be classified as resectable disease and whether curative resection can have a prognostic impact.

Methods

Between 1998 and 2010, a total of 47 ICC patients underwent hepatic resection and systematic lymphadenectomy with curative intent. We routinely dissected the PANs and had frozen-section pathological examinations performed intraoperatively. If PAN metastases were identified, curative resection was abandoned. We retrospectively investigated the prognostic factors for patient survival after curative resection for ICC without PAN metastases, with particular attention paid to the prognostic impact of lymphadenectomy.

Results

Univariate analysis identified concomitant portal vein resection, concomitant hepatic artery resection, intraoperative blood loss, intraoperative transfusion, and residual tumor as significant negative prognostic factors. However, lymph node status was not identified as a significant prognostic factor. The 14 patients with node-positive cancer had a survival rate of 20 % at 5 years. Based on multivariate analysis, intraoperative transfusion was an independent prognostic factor associated with a poor prognosis (risk ratio = 4.161; P = 0.0056).

Conclusions

Regional lymph node metastasis in ICC should be classified as resectable disease, because the survival rate after surgical intervention was acceptable when PAN metastasis was pathologically negative.
Literatur
1.
Zurück zum Zitat Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211:277–287 Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211:277–287
2.
Zurück zum Zitat Chen MF (1999) Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol 14:1144–1149PubMedCrossRef Chen MF (1999) Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol 14:1144–1149PubMedCrossRef
3.
Zurück zum Zitat Ikai I, Itai Y, Okita K et al (2004) Report of the 15th follow-up survey of primary liver cancer. Hepatol Res 28:21–29PubMedCrossRef Ikai I, Itai Y, Okita K et al (2004) Report of the 15th follow-up survey of primary liver cancer. Hepatol Res 28:21–29PubMedCrossRef
4.
5.
Zurück zum Zitat Okabayashi T, Yamamoto J, Kosuge T et al (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383PubMedCrossRef Okabayashi T, Yamamoto J, Kosuge T et al (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92:2374–2383PubMedCrossRef
6.
Zurück zum Zitat Nanashima A, Sumida Y, Abo T et al (2007) Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology 54:2337–2342PubMed Nanashima A, Sumida Y, Abo T et al (2007) Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology 54:2337–2342PubMed
7.
Zurück zum Zitat Uenishi T, Kubo S, Yamazaki O et al (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422PubMedCrossRef Uenishi T, Kubo S, Yamazaki O et al (2008) Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 15:417–422PubMedCrossRef
8.
Zurück zum Zitat Tamandl D, Herberger B, Gruenberger B et al (2008) Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 5:2787–2794CrossRef Tamandl D, Herberger B, Gruenberger B et al (2008) Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 5:2787–2794CrossRef
9.
Zurück zum Zitat Lang H, Sotiropoulos GC, Sgourakis G et al (2009) Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208:218–228PubMedCrossRef Lang H, Sotiropoulos GC, Sgourakis G et al (2009) Operations for intrahepatic cholangiocarcinoma: single-institution experience of 158 patients. J Am Coll Surg 208:218–228PubMedCrossRef
10.
Zurück zum Zitat Zhang L, Cai JQ, Zhao JJ et al (2010) Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 101:233–238PubMedCrossRef Zhang L, Cai JQ, Zhao JJ et al (2010) Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 101:233–238PubMedCrossRef
11.
Zurück zum Zitat Miwa S, Miyagawa S, Kobayashi A et al (2006) Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41:893–900PubMedCrossRef Miwa S, Miyagawa S, Kobayashi A et al (2006) Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41:893–900PubMedCrossRef
12.
Zurück zum Zitat Shen WF, Zhong W, Xu F et al (2009) Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 15:5976–5982PubMedCentralPubMedCrossRef Shen WF, Zhong W, Xu F et al (2009) Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol 15:5976–5982PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Choi SB, Kim KS, Choi JY et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16:3048–3056PubMedCrossRef Choi SB, Kim KS, Choi JY et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16:3048–3056PubMedCrossRef
15.
Zurück zum Zitat Shirabe K, Mano Y, Taketomi A et al (2010) Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol 17:1816–1822PubMedCrossRef Shirabe K, Mano Y, Taketomi A et al (2010) Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Ann Surg Oncol 17:1816–1822PubMedCrossRef
16.
Zurück zum Zitat Uchiyama K, Yamamoto M, Yamaue H et al (2011) Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 18:443–452PubMedCrossRef Uchiyama K, Yamamoto M, Yamaue H et al (2011) Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci 18:443–452PubMedCrossRef
17.
Zurück zum Zitat Pedrazzoli S, DiCarlo V, Dionigi R et al (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508–517PubMedCentralPubMedCrossRef Pedrazzoli S, DiCarlo V, Dionigi R et al (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 228:508–517PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Kondo S, Nimura Y, Hayakawa N et al (2000) Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg 87:418–422PubMedCrossRef Kondo S, Nimura Y, Hayakawa N et al (2000) Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma. Br J Surg 87:418–422PubMedCrossRef
19.
Zurück zum Zitat Farnell MB, Aranha GV, Nimura Y et al (2008) The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence. J Gastrointest Surg 12:651–656PubMedCrossRef Farnell MB, Aranha GV, Nimura Y et al (2008) The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence. J Gastrointest Surg 12:651–656PubMedCrossRef
20.
Zurück zum Zitat Shimada H, Endo I, Togo S et al (1997) The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 79:892–899PubMedCrossRef Shimada H, Endo I, Togo S et al (1997) The role of lymph node dissection in the treatment of gallbladder carcinoma. Cancer 79:892–899PubMedCrossRef
21.
Zurück zum Zitat Kitagawa Y, Nagino M, Kamiya J et al (2001) Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233:385–392PubMedCentralPubMedCrossRef Kitagawa Y, Nagino M, Kamiya J et al (2001) Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233:385–392PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C (2010) International Union Against Cancer (UICC) TNM classification of malignant tumours, 7th edn. Wiley-Liss, New York, pp 114–117 Sobin LH, Gospodarowicz MK, Wittekind C (2010) International Union Against Cancer (UICC) TNM classification of malignant tumours, 7th edn. Wiley-Liss, New York, pp 114–117
23.
Zurück zum Zitat Liver Cancer Study Group of Japan (2008) Macroscopic gross type. The general rules for the clinical and pathological study of primary liver cancer, 5th edn. Kanehara, Tokyo, pp 17–18 Liver Cancer Study Group of Japan (2008) Macroscopic gross type. The general rules for the clinical and pathological study of primary liver cancer, 5th edn. Kanehara, Tokyo, pp 17–18
24.
Zurück zum Zitat Yamashita Y, Taketomi A, Morita K et al (2008) The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res 28:2353–2359PubMed Yamashita Y, Taketomi A, Morita K et al (2008) The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res 28:2353–2359PubMed
25.
Zurück zum Zitat Paik KY, Jung JC, Heo JS et al (2008) What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23:766–770PubMedCrossRef Paik KY, Jung JC, Heo JS et al (2008) What prognostic factors are important for resected intrahepatic cholangiocarcinoma? J Gastroenterol Hepatol 23:766–770PubMedCrossRef
26.
Zurück zum Zitat Ohtsuka M, Ito H, Kimura F et al (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89:1525–1531PubMedCrossRef Ohtsuka M, Ito H, Kimura F et al (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 89:1525–1531PubMedCrossRef
28.
Zurück zum Zitat Noji T, Kondo S, Hirano S et al (2005) CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer. J Gastroenterol 40:739–743PubMedCrossRef Noji T, Kondo S, Hirano S et al (2005) CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer. J Gastroenterol 40:739–743PubMedCrossRef
29.
Zurück zum Zitat Imai H, Doi R, Kanazawa H et al (2010) Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer. Int J Clin Oncol 15:294–300PubMedCrossRef Imai H, Doi R, Kanazawa H et al (2010) Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer. Int J Clin Oncol 15:294–300PubMedCrossRef
30.
Zurück zum Zitat Sugezawa A, Kaibara N, Sumi K et al (1989) Blood transfusion and the prognosis of patients with gastric cancer. J Surg Oncol 42:113–116PubMedCrossRef Sugezawa A, Kaibara N, Sumi K et al (1989) Blood transfusion and the prognosis of patients with gastric cancer. J Surg Oncol 42:113–116PubMedCrossRef
31.
Zurück zum Zitat Ojima T, Iwahashi M, Nakamori M et al (2009) Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 13:1821–1830PubMedCrossRef Ojima T, Iwahashi M, Nakamori M et al (2009) Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. J Gastrointest Surg 13:1821–1830PubMedCrossRef
32.
Zurück zum Zitat Asahara T, Katayama K, Itamoto T et al (1999) Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 23:676–680. doi:10.1007/PL00012367 PubMedCrossRef Asahara T, Katayama K, Itamoto T et al (1999) Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg 23:676–680. doi:10.​1007/​PL00012367 PubMedCrossRef
33.
Zurück zum Zitat Makino Y, Yamanoi A, Kimoto T et al (2000) The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 95:1294–1300PubMedCrossRef Makino Y, Yamanoi A, Kimoto T et al (2000) The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol 95:1294–1300PubMedCrossRef
34.
Zurück zum Zitat Chung M, Steinmetz OK, Gordon PH (1993) Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 80:427–432PubMedCrossRef Chung M, Steinmetz OK, Gordon PH (1993) Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg 80:427–432PubMedCrossRef
35.
Zurück zum Zitat Yeh JJ, Gonen M, Tomlinson JS et al (2007) Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. Br J Surg 94:466–472PubMedCrossRef Yeh JJ, Gonen M, Tomlinson JS et al (2007) Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas. Br J Surg 94:466–472PubMedCrossRef
36.
Zurück zum Zitat Salvadori S, Martinelli G, Zier K (2000) Resection of solid tumors reverses T cell defects and restores protective immunity. J Immunol 164:2214–2220PubMedCrossRef Salvadori S, Martinelli G, Zier K (2000) Resection of solid tumors reverses T cell defects and restores protective immunity. J Immunol 164:2214–2220PubMedCrossRef
37.
Zurück zum Zitat Clark E, Connor S, Taylor MA et al (2007) Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma. HPB (Oxford) 9:472–477CrossRef Clark E, Connor S, Taylor MA et al (2007) Perioperative transfusion for pancreaticoduodenectomy and its impact on prognosis in resected pancreatic ductal adenocarcinoma. HPB (Oxford) 9:472–477CrossRef
Metadaten
Titel
Pathological Confirmation of Para-Aortic Lymph Node Status as a Potential Criterion for the Selection of Intrahepatic Cholangiocarcinoma Patients for Radical Resection with Regional Lymph Node Dissection
verfasst von
Tomohide Nakayama
Takahiro Tsuchikawa
Toshiaki Shichinohe
Toru Nakamura
Yuma Ebihara
Satoshi Hirano
Publikationsdatum
01.07.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 7/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2433-7

Weitere Artikel der Ausgabe 7/2014

World Journal of Surgery 7/2014 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.